ASTROTECH Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ASTROTECH Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	2.33	0.09	0.13	0.49	0.33	0.87	0.75	1.7	1.05	0.91
Cost of revenue	1.29	0.04	0.09	0.45	0.3	0.68	0.44	0.91	0.57	0.7
Gross profit	1.04	0.05	0.04	0.04	0.04	0.19	0.31	0.75	0.48	0.22
Research and development	5.59	6.07	3.58	3.44	2.69	2.78	5.59	6.79	8.14	6.48
Selling, general and administrative	7.51	5.63	4.88	4.72	4.74	6.01	5.78	7.24	7.07	7.87
Operating expenses	13.1	13.4	8.45	8.15	7.95	8.79	11.4	14	15.2	14.4
Operating income	-12.1	-13.3	-8.42	-8.11	-7.91	-8.6	-11.1	-13.3	-14.7	-14.1
Interest income									1.09	0.47
Other non-operating income	0.31	0.09	0.03	-0.2	-0.24	0.27	1.42	1.62	0.89	-0.29
Pre-tax income	-11.8	-13.3	-8.39	-8.31	-7.6	-8.33	-9.64	-11.7	-13.8	-14.4
Income tax	0	0	-0.86	0	0	0	0	0	0	0
Net income to minority interests	-0.17	0
Net income	-11.6	-13.3	-7.53	-8.31	-7.6	-8.33	-9.64	-11.7	-13.9	-14.4
EBITDA	-11.3	-12.6	-8.15	-7.58	-7.71	-8.36	-10.7	-12.5	-13.8	-13.2
EPS, basic	-2.84	-3.26	-1.53	-1.31	-0.35	-5.24	-5.95	-7.12	-8.32	-8.49
EPS, diluted	-2.84	-3.26	-1.53	-1.31	-0.35	-5.24	-5.95	-7.12	-8.32	-8.49
Shares, basic (weighted)	4.08	4.06	4.94	6.35	22	1.59	1.62	1.64	1.67	1.7
Shares, diluted (weighted)	4.08	4.06	4.94	6.35	22	1.59	1.62	1.64	1.67	1.7

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	2.18	0.55	1.59	3.35	35.9				3.1	8.39
Short-term investments	10.9	3.55		0	27.4	26.2	27.9	21.5	15.1	2.95
Receivables	0.15	0.01	0	0.1	0.01	0.06	0.23	0.08	0.49	0.12
Inventory	0.17	0.01			0.3	0.52	0.37	0.37	0.31	1.18
Other current assets	0.27	0.15	0.37	0.12	0.32	0.75	0.37	0.26	0.35	0.35
Total current assets	13.7	4.28	2.72	4.67	65.1	55	44.7	34.7	22	15.9
Property, plant and equipment	3.18	0.73	0.47	0.1	0.26	1.1	2.67	2.76	2.4	2.38
Lease right-of-use assets				0.85	0.25	0.16	0.26	0.12	2.23	1.83
Intangible assets								0	0.05	0.05
Long-term investments	1.99	0.05				0	0	0	0	0
Other non-current assets	0	0.08	0.07	0.07	0.01	0.01	0.03	0.03	0.35	0.31
Total assets	18.8	5.14	3.69	5.93	65.6	56.2	47.7	37.6	27	20.5
Accounts payable	0.26	0.11	0.16	0.24	0.4	0.17	0.55	0.37	1.07	0.58
Accrued liabilities	0.64	0.41	0.32	0.43	0.34	0.82	0.63	1.17	0.53	0.48
Deferred revenue	0
Total current liabilities	1.81	0.96	0.84	4.35	4.21	2.68	2.67	2.53	2.45	2.26
Long-term debt				0.33
Lease liabilities				0.58	0.19		0.13	0	2.23	2
Other non-current liabilities	0.26	0.19	0.15
Total liabilities	2.07	1.15	0.98	5.31	4.43	2.99	2.96	2.83	4.89	4.34
Total debt	0	0
Paid-in capital	1.48	1.75	7.96	13.9	78	79.5	81	82.5	83.3	91.3
Retained earnings	-171	-184	-192	-200	-207	-216	-225	-237	-251	-265
Treasury stock	-4.12	-4.13	-4.13	-4.13		0	-0.12	-0.12	-0.12	-0.12
Other comprehensive income	-0.06	-0.03			-0.02	-1.2	-1.45	-1.18	-0.86	-0.32
Shareholders' equity	16.8	3.99	2.71	0.63	61.2	53.2	44.7	34.8	22.1	16.2
Minority interests	0	0
Total equity	16.8	3.99	2.71	0.63	61.2	53.2	44.7	34.8	22.1	16.2
Total liabilities and equity	18.8	5.14	3.69	5.93	65.6	56.2	47.7	37.6	27	20.5
Shares outstanding	4.11	4.1	5.78	7.85	49.5	1.69	1.68	1.7	1.76	2

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-11.8	-13.3	-7.53	-8.31	-7.6	-8.33	-9.64	-11.7	-13.9	-14.4
Depreciation and amortization	0.71	0.75	0.27	0.53	0.2	0.24	0.37	0.73	0.96	0.9
Stock-based compensation	1.13	0.45	0.31	0.35	0.63	1.54	1.5	1.48	0.83	0.92
Deferred income tax		0	-0.43	0	0	0	0	0	0	0
Change in receivables	0.01	0.13	0.01	-0.1	0.1	-0.05	-0.17	0.15	-0.41	0.36
Change in inventory		0	-0.32	-0.35	-0.82	-0.02	-0.48	-0.48	-0.46	-1.37
Change in payables	0.02	-0.15	0.05	0.08	0.16	-0.23	0.38	-0.17	0.69	-0.49
Cash from operations	-8.82	-10.8	-8.48	-6.93	-7.4	-6.79	-7.63	-9.73	-13	-13.5
Capital expenditures	-0.5	-0.02	0	0	-0.21	-0.6	-1.84	-0.58	-0.83	-0.88
Purchases of investments				0	-27.4	0
Sales and maturities of investments	4.64	1.95	0.25	0					6.68	12.7
Cash from investing	7.88	9.16	3.6	0	-27.6	-0.6	-3.84	6.14	5.8	11.8
Stock issued	0.02	0	5.91	5.65	67.6	0			0	6.69
Share buybacks	-1.29	-0.01	-0	0		0	-0.12	0
Cash from financing	-1.28	-0.01	5.91	8.69	67.6	-2.1	-0.78	-0.18	-0.19	6.92
Net change in cash	-2.22	-1.63	1.04	1.76	32.6	-9.48	-12.2	-3.77	-7.34	5.29
Free cash flow	-9.32	-10.8	-8.48	-6.93	-7.61	-7.39	-9.47	-10.3	-13.8	-14.3
Interest paid	0	0	0	0	0	0.52	0.07	0.03	0.01	0
Income taxes paid	0	0	0	0	0	0	0	0	0	0

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $7.16 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	23.8%	Gross profit / revenue.
Operating margin	-1,549.0%	Operating income / revenue.
EBITDA margin	-1,450.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1,580.0%	Pre-tax income / revenue.
Net margin	-1,580.0%	Net income / revenue.
FCF margin	-1,570.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-1,473.0%	Cash from operations / revenue.
Return on equity (ROE)	-75.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-60.8%	Net income / average total assets.
Return on invested capital (ROIC)	-83.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	710.2%	Research and development expense / revenue.
SG&A / revenue	862.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	100.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	96.3%	Capital expenditures / revenue.
D&A / revenue	98.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-13.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	22.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-54.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-10.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	43.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-26.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-28.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-23.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-24.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-24.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-20.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-40.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	7.06x	Current assets / current liabilities.
Quick ratio	5.08x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	5.02x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	21.1%	Total liabilities / total assets.
Working capital	$13.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$16.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.04x	Revenue / average total assets.
Fixed asset turnover	0.38x	Revenue / average property, plant and equipment.
Inventory turnover	0.93x	Cost of revenue / average inventory.
Days inventory	390 days	365 x average inventory / cost of revenue.
Receivables turnover	3.00x	Revenue / average receivables.
Days sales outstanding	122 days	365 x average receivables / revenue.
Days payables	432 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	80 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$8.49	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$8.49	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.54	Revenue / diluted weighted shares.
FCF per share	-$8.43	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$7.91	Cash from operations / diluted weighted shares.
Book value per share	$8.09	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$8.07	Tangible book value / shares outstanding.
Cash per share	$5.67	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$14.4M	Share price x shares outstanding.
Enterprise value	$3.0M	Market cap + total debt - cash - short-term investments.
P/S	15.7x	Market cap / revenue.
P/B	0.89x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.89x	Market cap / tangible book value, when positive.
EV/Sales	3.33x	Enterprise value / revenue.
FCF yield	-99.7%	Free cash flow / market cap.
Earnings yield	-100.4%	Net income / market cap (the inverse of P/E).

What was ASTROTECH Corp's revenue in fiscal 2026?

ASTROTECH Corp reported revenue of $913.0K for fiscal 2026, 13% lower than the year before.

Was ASTROTECH Corp profitable in fiscal 2026?

No. It reported a net loss of $14.4M.

How much free cash flow did ASTROTECH Corp generate in fiscal 2026?

Cash from operations of $13.5M minus capital expenditures of $879.0K left free cash flow of -$14.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ASTROTECH Corp